Ridge Diagnostics, Inc., a neurodiagnostic company, announced that data from clinical studies for its first-in-class, proprietary blood test for Major Depressive Disorder(MDD), will be presented during a poster session entitled Multianalyte Biomarker Blood Test to Aid in Diagnosis, Treatment and Management of Major Depressive Disorder, at the American Psychiatric Association Annual Meeting, May 20, 2009.
Popularity: unranked [?]
Related posts:
- American Psychiatric Publishing, Inc. Releases Cutting-Edge Titles
- New Study Results Provide Additional Data About Short- And Long-Term Use Of Desvenlafaxine Succinate In The Treatment Of Major Depressive Disorder
- Desvenlafaxine Succinate (DVS-233) Phase 3 Data Show Significant Improvement In Symptoms Of Depression In Adult Patients Versus Placebo
- Seroquel Evaluation On Improvement In Short And Long-Term Symptoms
- Treating Depression In Pregnancy
Comments
No Responses to “Ridge Diagnostics, Inc. Clinical Data On Blood Test For Depression Presented At American Psychiatric Association Annual Meeting”